Venous thromboembolism risk in patients with hormone...

  • Main
  • 2020 / 7
  • Venous thromboembolism risk in patients with hormone...

Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials

Thein, Kyaw Zin, Htut, Thura Win, Ball, Somedeb, Swarup, Sriman, Sultan, Anita, Oo, Thein Hlaing
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-020-05783-3
Date:
July, 2020
File:
PDF, 1.05 MB
2020
Conversion to is in progress
Conversion to is failed